Delivery Order SPE2DB22D9367-SPE2DB24FSY65

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,326.31 firm fixed-price contract is for the delivery of Erythromycin Ophthalmic, a prescription antibiotic eye solution. This delivery order is part of a larger single-award indefinite delivery contract (IDC), valued at up to $499,999,999, held by DMS Pharmaceutical Group with the DLA under...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $1,063.40 contract is for the delivery of Erythromycin 0.5% Eye Ointment. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, valued up to $4,999,999 through 2025, which enables the agency to place orders for a broad range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,786.44, is for the supply of the drug erythromycin ophthalmic to support the recurring medical needs of military health facilities. The contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,330.04 firm fixed-price contract is for the supply of Erythromycin 0.5% eye ointment 3.5g. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,325.60 award is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams. This order is part of a larger indefinite delivery contract (IDV), contract number SPE2DB24FZR72, with a ceiling value of up to $4,999,999 that DMS Pharmaceutical Group holds with DLA to provide a broad range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,595.10, is a firm fixed-price delivery order for the supply of Erythromycin 0.5% eye ointment. The contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,326.31 award is for the delivery of erythromycin ophthalmic solution, a branded pharmaceutical product. This delivery order is part of a larger $499,999,999 indefinite delivery contract that allows the DLA to issue firm fixed-price orders for a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4564081912 - Erythromycin 0.5% Eye Ointment. The contract has a ceiling value of $2,658.50 and a completion date of March 27, 2024. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract #4600082013 with the DLA, valued up to $4,999,999 through 2025, which enables DLA to issue delivery orders...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Erythromycin Ophthalmic, a medical product, with a ceiling value of $1,695.75 and a period of performance through March 6, 2025. The contract is not set aside for any specific socioeconomic program. DMS Pharmaceutical Group Inc....
This federal contract award, valued at $1,860.95, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of Erythromycin 0.5% eye ointment to the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with the DLA under the...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSY65
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,063.40 contract is for the delivery of Erythromycin 0.5% eye ointment to support the medical supply needs of military health facilities.

The contract is issued under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items. This vehicle, under the SPE2DB program, enables DMS Pharmaceutical Group to provide a vast array of both common and specialized medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities. There is no set-aside designation for this specific delivery order.

Generated 10/8/24, 9:14 AM